Back to
WELLINGTON MANAGEMENT GROUP LLP
CLDX23 quarters
Position history for
WELLINGTON MANAGEMENT GROUP LLP's holdings in CELLDEX THERAPEUTICS INC NEW
Yes. Wellington Management Group holds 9,543,671 shares of CLDX (Celldex Therapeutics), worth $355.1M, as of its Q2 2026 13F filing. It increased the position by 983,195 shares (+11.5%) from Q1 2026. Wellington Management Group has held CLDX since Q4 2020, across 23 quarterly 13F filings. CLDX is 0.1% of Wellington Management Group's reported 13F portfolio.
Current Value
$355.1M
Current Shares
9.5M
Total Value Change
+$353.5M
Total Shares Change
+9.4M
Quarter-by-Quarter History
Other major holders of CLDX: FMR LLC